1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Sulindac 400 MG: new trials by email Literature Review of Sulindac 400 MG trials Research Report on Sulindac 400 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Sulindac 400 MG, Placebo - IPMN, IPMN, Pancreatic | Phase 2 | Active not recruiting | Duke University | 100 | 2020-07-10 | 2026-09-08 |
Pancreatic Intraductal Neoplasms (1)
Duke University (1)
United States (1)
Peter Allen, MD (1)
R01CA235677 (1)